| Appalachian Behavioral Health Care | |
| 100 Hospital Drive, Athens, Ohio 45701 | |
| (740) 594-5000 | |
| Not Available |
| Name | Appalachian Behavioral Health Care |
|---|---|
| Type | Psychiatric Hospital |
| Location | 100 Hospital Drive, Athens, Ohio |
| Ownership | Proprietary |
| Emergency Services | No |
| Medicare ID (CCN) | 364015 |
| NPI Number | 1063486058 |
| Organization Name | STATE OF OHIO OFFICE OF BUDGET AND MANAGEMENT STATE ACCOUNTING |
| Doing Business As | APPALACHIAN BEHAVIORAL HEALTHCARE, ATHENS CAMPUS |
| Address | 100 Hospital Dr, Athens, OH 45701 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 614-594-5000 |
News Archive
Researchers from Mount Sinai School of Medicine have identified a six-gene signature that can be used in a test to predict survival in men with aggressive prostate cancer, according to new research published in the October issue of The Lancet Oncology.
A specific molecule involved in maintaining pain after a nerve injury has been identified and blocked in mice by Hiroshima University researchers. These results reveal a promising therapeutic strategy for treating neuropathic pain.
Scientists have long wondered how melanoma cells travel from primary tumors on the surface of the skin to the brain, liver and lungs, where they become more aggressive, resistant to therapy, and deadly.
Cognition Therapeutics Inc., a drug discovery company developing novel, small molecule disease-modifying treatments for Alzheimer's, has closed on a $2.5 million Series A1 financing it will use to bring one or more of its compounds to Investigational New Drug (IND) candidate status. The round was led by Golden Seeds, one of the nation's largest angel investing groups, and was syndicated with Tech Coast Angels.
Primary school children should not be routinely screened for obesity without any sound evidence of benefit, suggests research published ahead of print in the Archives of Disease in Childhood.
› Verified 4 days ago
News Archive
Researchers from Mount Sinai School of Medicine have identified a six-gene signature that can be used in a test to predict survival in men with aggressive prostate cancer, according to new research published in the October issue of The Lancet Oncology.
A specific molecule involved in maintaining pain after a nerve injury has been identified and blocked in mice by Hiroshima University researchers. These results reveal a promising therapeutic strategy for treating neuropathic pain.
Scientists have long wondered how melanoma cells travel from primary tumors on the surface of the skin to the brain, liver and lungs, where they become more aggressive, resistant to therapy, and deadly.
Cognition Therapeutics Inc., a drug discovery company developing novel, small molecule disease-modifying treatments for Alzheimer's, has closed on a $2.5 million Series A1 financing it will use to bring one or more of its compounds to Investigational New Drug (IND) candidate status. The round was led by Golden Seeds, one of the nation's largest angel investing groups, and was syndicated with Tech Coast Angels.
Primary school children should not be routinely screened for obesity without any sound evidence of benefit, suggests research published ahead of print in the Archives of Disease in Childhood.
› Verified 4 days ago
Ohiohealth O'bleness Hospital Acute Care Hospital Location: 55 Hospital Drive, Athens, Ohio 45701 Phone: (740) 593-5551 | |
Appalachian Behavioral Health Care Psychiatric Hospital Location: 100 Hospital Drive, Athens, Ohio 45701 Phone: (740) 594-5000 |